Recap: Rigel Pharmaceuticals Q4 Earnings

Rigel Pharmaceuticals RIGL reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Rigel Pharmaceuticals beat estimated earnings by 15.38%, reporting an EPS of $-0.11 versus an estimate of $-0.13.

Revenue was up $1.96 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 2.52% drop in the share price the next day.

Here's a look at Rigel Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.